London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi
Has anyone worked out what the cash pile is now, given the 20% increase in revenues (non DHSC)?
Thanks
It’s £77m H1 Cash + July, August and September, so c.£87m IMO for Q3 YTD
What ever the cash pile is,would be nice for our sp if we bought some shares back,by christ the sp needs something to steady it,cos the company cant.
Personally dont think anyone can write off the whole of the pile set aside for Dhsc dispute, as if as they say they have a "good case" that could easily pump a fair chunk of it, back in, to cash pile!!!
+£10m corporation tax credit. Assuming no resultion to the dispute by YE we're possibly looking at around £110m cash, perhaps more when you take into account £8.3m VAT credit which will offset VAT against sales in H2.
Yeah it's a difficult hold this one. The sad thing is no matter how low it gets you just know you'll wake up tomorrow and it will be down another 2-3%. Personally I loathe owning these shares now, but thats my heart, my head looks at the cash and the earnings and tells me its a no brainer hold. That said my faith in the company is non existent at the moment, they need to do something to turn it around pretty soon or they wont have any investors left.
Bluelight, it gets even more depressing when you consider only 2% of the company is in institutional hands, 2 bloody percent. Vatel probably hold at least 1.5% due to them having to hold 1m until next year. So let's be very generous and say 5% in institutional hands. What on earth are we paying the likes of numis for?
This is the worst institutionally supported company I've come across in over 20 years. A company making good money developing world class products with half its market cap in cash can't even attract the interest that debt ridden explorers do.
Anybody know a worse supported company? I'm really struggling to come up with one.
This dispute is throttling us in every way imaginable.
Looks like katalyst believe in us Tks Larry
https://twitter.com/Larry64450205/status/1442521324149166080
Just looked at that tweet, which I hope is bona fide but where is the proof of association with BBC? Looks like a photo of a lab with 2 Q32s that could be anywhere or a mock up for a promotion photo! Not wishing to put a downer on it but..
Fonzey
Sir_digby can't disagree with any of that utterly bizzarre.
Yep they have really screwed investors and discouraged it as an investment. I'd usually be banging the drum to friends to get involved, but can't bring myself to do it anymore as they'd probably lose money. They say it always darkest before the dawn but its been pitch black since January. Anyway, stuck with it I guess, but it would be nice if they did something positive for investors for a change, some straw to clutch. How would anyone in their right mind invest given how the company have f'ed it up this year.. They need to find a way to change perceptions
Fonzey in fairness I've ran it on trust on Larry as he normally nails everything, I've looked at a couple of options but haven't found his photo source and he may not reveal....Larry?
Fonzey I've found it but I'm not posting as it's someone's LinkedIn page , key words will get you there not being awkward.
For once i dont put a source on a fact lol.
Believe it or dont, no problem if you dont.
Thanks for sharing it here Wilson.
Larry I Iike the linked in page of the head of Katalyats operations. Take a look all , very extensive list of what he is busy doing including 25 sites.
That's fine Wilson! As long as there is something to corroborate it! All good. Thanks
For those that haven't seen it this is the section of last autumns contract that deal's security of supply.
22 / Security of supply
Upon the signing of this order form all reagent kit's will be available to the NHS. The supply of the further (blank) optional qpcr instrument's will follow upon the placing of a further order by the Authority. The Authority may place that order up to 8 week's after the date of this agreement, failing which the Supplier may release it's stock to other customers. The Supplier shall maintain the flexibility and scope within its manufacturing capacity to increasing demand across its full range of product's.
The Suppliers goods are manufactured in the UK and are available for supply secure from the impact of the risk's arising from the UK's exit from the EU or from US export restrictions.
The Supplier confirms that it is able to meet the Authority's current anticipated demand forecast of approximately ( blank) Exsig Direct per week for Phase 1 and further anticipated demand in the optional phase. The Supplier confirms that it is able to scale up manufacturing to provide greater volumes if requested.
It looks very much like Novacyt did what asked of them to guarantee supply under the term's of the contract.
Is this really an extract from the contract? Can't believe the person writing it didn't have a clue how to use apostrophes.
FFS.
US market. The number of tests sold per month in H1 2021 appears to be lower than H1 2020! This is in a country where between January & June 2020, 37 million tests were carried. Between Jan 2021 and June 2021 213 million tests were carried out.
Middle East, I already posted on. Sales less now than in pre-covid times.
Africa, down on last year.
Europe, take out the Ukraine contract and the sales are about half of what they were last year.
All this when testing in 2021 is significantly higher than 2020. USA testing this year to date is up 20 fold on 2020. Said it before but why would anyone doing due dilligence authorise a major contract with a company that was in dispute with their biggest Client?
Not quite sure what some of the new management are doing other than stealing a wage by the looks of it. They need to announce some forward thinking or any value left for shareholders is going to disappear, faster than snow of a dyke.
**** of a share!
So marrying up Exmex's with hill seekers comment my take is we ramped up for dhsc2 and didn't get It, the absolute beauty of this is they can supply large orders at the drop of a hat and build up inventory if required.
Company tweet
https://twitter.com/NovacytGroup/status/1442537551588384770
I see alot of those comments underneath pretty much match most investors sentiments, as much as I'm against posting on replies to them. Growing sentiment investors are suffering whilst ncyt benefits through bonuses. Be interesting how the vote on that goes on Wed. But can't disagree with them right now
We've seen at 76.5% drop in share price this year, and they want us to support executive bonus incentives. Phrase you can F right off springs to my mind.
I wonder how long it will be till the launch of the automated extraction and sample preparation unit that they mentioned today .A picture of this was first shown in the recent investor presentation. This unit combined with the PROmate chemistry should really simplify their POCT setup.